Related Experiment Video
Updated: Jun 17, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Targeted therapy in biliary tract cancer: 2009 update
Giuseppe Tonini1, Vladimir Virzì, Maria Elisabetta Fratto
1Department of Medical Oncology, University Campus Bio-Medico, 00128 Rome, Italy. g.tonini@unicampus.it
Future Oncology (London, England)
|December 17, 2009
Summary
New targeted therapies offer hope for advanced biliary tract cancers (BTCs), including cholangiocarcinoma. This review analyzes prognostic factors, molecular features, and clinical trials of targeted agents like anti-EGFR drugs.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Biliary tract cancers (BTCs) encompass a group of aggressive malignancies with poor prognosis in advanced stages.
- Current treatment strategies lack consensus, and chemotherapy demonstrates limited efficacy.
Purpose of the Study:
- To review novel therapeutic approaches for BTC patients.
- To analyze prognostic factors and molecular characteristics of BTC.
- To summarize clinical trials of targeted therapies, including anti-EGFR and antiangiogenic drugs.
Main Methods:
- Literature review of recent clinical trials and research studies on BTC.
- Analysis of prognostic factors and molecular profiling of biliary tract cancers.
- Description of ongoing clinical trials evaluating targeted agents.
Main Results:
- Targeted therapies, particularly anti-EGFR and antiangiogenic agents, show promise in clinical trials.
- Understanding molecular features is crucial for selecting effective targeted treatments.
- Ongoing trials are essential to determine optimal therapeutic strategies.
Conclusions:
- Targeted therapies represent a promising frontier for advanced BTC management.
- Further results from ongoing clinical trials are needed to establish definitive treatment protocols.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.